Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Mental Health Awareness Month: Fighting the growing mental health crisis and supporting innovation

By Andrew Powaleny  |    May 11, 2023
America is currently facing a mental health crisis — one that is impacting families and individuals in every community, with the COVID-19 pandemic only exacerbating these trends. Mental Health...   Read More

Support for continued progress is critical for pediatric drug development

By Abigail Lore  |    May 8, 2023
Researching and developing new medicines for children is a priority for the biopharmaceutical industry. Despite the scientific complexity and challenges inherent to developing treatments for our...   Read More

New Report: More than 400 medicines in development for leading chronic conditions affecting older Americans

By Lucy Vereshchagina  |    March 28, 2023
Chronic diseases like Alzheimer’s disease, diabetes and kidney disease disproportionately affect older adults. In the United States, nearly 95% of older adults have at least one chronic condition and...   Read More

State policymakers can protect American innovation and help Americans live longer, healthier lives

By Mark Reisenauer and Stephen J. Ubl  |    February 9, 2023
For the second year in a row, life expectancy is on the decline in America. The leading causes of death across the United States include cancer and chronic diseases. Even when patients are able to...   Read More

Recognizing National Glaucoma Awareness Month

By Matthew Norawong  |    February 1, 2023
January was National Glaucoma Awareness Month and provided us an opportunity to spread the word and honor the millions of patients around the world who are impacted by this debilitating disease.   ...   Read More

New Report: More than 160 medicines in development for mental illness

By Matthew Norawong  |    January 26, 2023
Mental illness represents a broad spectrum of health conditions affecting mood, thinking and behavior. These conditions include depression, bipolar disorder, schizophrenia, substance use disorder,...   Read More

ICYMI: Cancer death rate continues to decline due to treatment advances

By Matthew Norawong  |    January 25, 2023
Earlier this month, the American Cancer Society (ACS) released its annual report, Cancer Statistics 2023, finding the overall cancer mortality rate has declined 33% since peaking in 1991, leading to...   Read More

Stories from the lab: Researchers discuss innovative treatments for cancers of the blood

By Matthew Norawong  |    December 1, 2022
The biopharmaceutical industry is one of the most research-intensive of all sectors in the U.S. economy and supports a broad range of STEM jobs through R&D and manufacturing. At the backbone of the...   Read More

New Report: Nearly 800 medicines in development to treat chronic conditions

By Matthew Norawong  |    September 29, 2022
Chronic conditions impose a substantial health and economic burden that affects millions of patients, families and communities across the United States each day. While these conditions come with...   Read More

Recognizing National Sickle Cell Awareness Month

By Anne McDonald Pritchett, PhD  |    September 23, 2022
September is National Sickle Cell Awareness Month and a time for us to underscore the biopharmaceutical industry’s ongoing commitment to improve the lives of patients, families and communities...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates